Patterns and predictors of recurrent acute care use among Medicaid beneficiaries with systemic lupus erythematosus
Copyright © 2020 Elsevier Inc. All rights reserved..
OBJECTIVES: We aimed to identify longitudinal patterns and predictors of acute care use (emergency department [ED] visits and hospitalizations) among individuals with SLE enrolled in Medicaid, the largest U.S. public insurance.
METHODS: Using Medicaid data (29 states, 2000-2010) we identified 18-65-year-olds with SLE (≥3 SLE ICD-9 codes, 3rd code=index date), ≥12 months of enrollment prior to the index date and ≥24 months post. For each 90-day interval post index date, patients were assigned binary indicators (1=≥1 ED visit or hospitalization, 0=none). We used group-based trajectory models to graph patterns of overall and SLE-specific acute care use, and multinomial logistic regression models to examine predictors.
RESULTS: Among 40,381 SLE patients, the mean age was 40.8 (SD 11.9). Using a three-group trajectory model, 2,342 (6%) were recurrent all-cause high acute care utilizers, 12,932 (32%) moderate, 25,107 (62%) infrequent; 25% were moderate or high utilizers for SLE. There were higher odds of all-cause, recurrent acute care use (vs. infrequent) among patients with severe vs. mild SLE (OR 3.37, 95% CI 3.0-3.78), chronic pain (odds ratio [OR] 1.63, 95% CI 1.15-2.32), depression (OR 1.90 95% CI 1.74-2.09), and cardiovascular disease (OR 2.29, 95% CI 2.08-2.52). Older age, male sex and hydroxychloroquine use were associated with lower odds of recurrent overall and SLE-specific acute care use.
CONCLUSION: Nearly 40% of Medicaid beneficiaries with SLE are recurrent all-cause acute care utilizers; 25% have recurrent use for SLE. Modifiable factors, including outpatient management of SLE and comorbidities, may reduce avoidable acute care use.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
---|---|
Enthalten in: |
Seminars in arthritis and rheumatism - 50(2020), 6 vom: 23. Dez., Seite 1428-1436 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Feldman, Candace H [VerfasserIn] |
---|
Links: |
---|
Themen: |
4QWG6N8QKH |
---|
Anmerkungen: |
Date Completed 29.09.2021 Date Revised 08.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.semarthrit.2020.02.012 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM30838315X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM30838315X | ||
003 | DE-627 | ||
005 | 20231225131624.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.semarthrit.2020.02.012 |2 doi | |
028 | 5 | 2 | |a pubmed24n1027.xml |
035 | |a (DE-627)NLM30838315X | ||
035 | |a (NLM)32252975 | ||
035 | |a (PII)S0049-0172(20)30065-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Feldman, Candace H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Patterns and predictors of recurrent acute care use among Medicaid beneficiaries with systemic lupus erythematosus |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.09.2021 | ||
500 | |a Date Revised 08.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
520 | |a OBJECTIVES: We aimed to identify longitudinal patterns and predictors of acute care use (emergency department [ED] visits and hospitalizations) among individuals with SLE enrolled in Medicaid, the largest U.S. public insurance | ||
520 | |a METHODS: Using Medicaid data (29 states, 2000-2010) we identified 18-65-year-olds with SLE (≥3 SLE ICD-9 codes, 3rd code=index date), ≥12 months of enrollment prior to the index date and ≥24 months post. For each 90-day interval post index date, patients were assigned binary indicators (1=≥1 ED visit or hospitalization, 0=none). We used group-based trajectory models to graph patterns of overall and SLE-specific acute care use, and multinomial logistic regression models to examine predictors | ||
520 | |a RESULTS: Among 40,381 SLE patients, the mean age was 40.8 (SD 11.9). Using a three-group trajectory model, 2,342 (6%) were recurrent all-cause high acute care utilizers, 12,932 (32%) moderate, 25,107 (62%) infrequent; 25% were moderate or high utilizers for SLE. There were higher odds of all-cause, recurrent acute care use (vs. infrequent) among patients with severe vs. mild SLE (OR 3.37, 95% CI 3.0-3.78), chronic pain (odds ratio [OR] 1.63, 95% CI 1.15-2.32), depression (OR 1.90 95% CI 1.74-2.09), and cardiovascular disease (OR 2.29, 95% CI 2.08-2.52). Older age, male sex and hydroxychloroquine use were associated with lower odds of recurrent overall and SLE-specific acute care use | ||
520 | |a CONCLUSION: Nearly 40% of Medicaid beneficiaries with SLE are recurrent all-cause acute care utilizers; 25% have recurrent use for SLE. Modifiable factors, including outpatient management of SLE and comorbidities, may reduce avoidable acute care use | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Health care utilization | |
650 | 4 | |a Health disparities | |
650 | 4 | |a Health services research | |
650 | 4 | |a Systemic lupus erythematosus | |
650 | 7 | |a Hydroxychloroquine |2 NLM | |
650 | 7 | |a 4QWG6N8QKH |2 NLM | |
700 | 1 | |a Xu, Chang |e verfasserin |4 aut | |
700 | 1 | |a Williams, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Collins, Jamie E |e verfasserin |4 aut | |
700 | 1 | |a Costenbader, Karen H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Seminars in arthritis and rheumatism |d 1971 |g 50(2020), 6 vom: 23. Dez., Seite 1428-1436 |w (DE-627)NLM000215643 |x 1532-866X |7 nnns |
773 | 1 | 8 | |g volume:50 |g year:2020 |g number:6 |g day:23 |g month:12 |g pages:1428-1436 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.semarthrit.2020.02.012 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 50 |j 2020 |e 6 |b 23 |c 12 |h 1428-1436 |